Division Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Amphia Academy Infectious Disease Foundation, Amphia Hospital, Breda, The Netherlands.
Trials. 2018 Jan 19;19(1):51. doi: 10.1186/s13063-018-2439-4.
Colorectal surgery is frequently complicated by surgical site infections (SSIs). The most important consequences of SSIs are prolonged hospitalization, an increased risk of surgical reintervention and an increase in mortality. Perioperative intravenously administered antibiotic prophylaxis is the standard of care to reduce the risk of SSIs. In the last few decades, preoperative orally administered antibiotics have been suggested as additional prophylaxis to further reduce the risk of infection, but are currently not part of routine practice in most hospitals. The objective of this study is to evaluate the efficacy of a preoperative orally administered antibiotic prophylaxis (Pre-OP) in addition to intravenously administered perioperative antibiotic prophylaxis to reduce the incidence of deep SSIs and/or mortality after elective colorectal surgery.
METHODS/DESIGN: The PreCaution trial is designed as a multicenter, double-blind, randomized, placebo-controlled clinical trial that will be carried out in The Netherlands. Adult patients who are scheduled for elective colorectal surgery are eligible to participate. In total, 966 patients will be randomized to receive the study medication. This will either be Pre-OP, a solution that consists of tobramycin and colistin sulphate, or a placebo solution. The study medication will be administered four times daily during the 3 days prior to surgery. Perioperative intravenously administered antibiotic prophylaxis will be administered to all patients in accordance with national infection control guidelines. The primary endpoint of the study is the cumulative incidence of deep SSIs and/or mortality within 30 days after surgery. Secondary endpoints include both infectious and non-infectious complications of colorectal surgery, and will be evaluated 30 days and/or 6 months after surgery.
To date, conclusive evidence on the added value of preoperative orally administered antibiotic prophylaxis in colorectal surgery is lacking. The PreCaution trial should determine the effects of orally administered antibiotics in preventing infectious complications in elective colorectal surgery.
Netherlands Trial Register, ID: NTR6113 . Registered on 11 October 2016; EudraCT 2015-005736-17.
结直肠手术常并发手术部位感染(SSI)。SSI 最重要的后果是延长住院时间、增加再次手术的风险和增加死亡率。围手术期静脉内给予抗生素预防是降低 SSI 风险的标准治疗方法。在过去几十年中,术前口服抗生素已被提议作为额外的预防措施,以进一步降低感染风险,但目前在大多数医院并非常规实践。本研究的目的是评估术前口服抗生素预防(Pre-OP)在降低择期结直肠手术后深部 SSI 和/或死亡率方面的疗效。
方法/设计:PreCaution 试验设计为一项多中心、双盲、随机、安慰剂对照临床试验,将在荷兰进行。计划接受择期结直肠手术的成年患者有资格参加。总共将有 966 名患者随机接受研究药物。这将是 Pre-OP,一种由妥布霉素和硫酸粘菌素组成的溶液,或安慰剂溶液。研究药物将在手术前 3 天每天给药 4 次。所有患者将根据国家感染控制指南给予围手术期静脉内给予抗生素预防。该研究的主要终点是手术后 30 天内深部 SSI 和/或死亡率的累积发生率。次要终点包括结直肠手术后的感染和非感染并发症,并将在手术后 30 天和/或 6 个月进行评估。
迄今为止,术前口服抗生素预防在结直肠手术中的附加价值尚无定论证据。PreCaution 试验应确定口服抗生素在预防择期结直肠手术中感染并发症方面的作用。
荷兰试验注册处,ID:NTR6113。注册于 2016 年 10 月 11 日;EudraCT 2015-005736-17。